CSDIX
Price
$19.27
Change
-$0.01 (-0.05%)
Updated
Jun 18 closing price
Net Assets
9.36B
JIREX
Price
$13.65
Change
+$0.05 (+0.37%)
Updated
Jun 18 closing price
Net Assets
335.69M
Interact to see
Advertisement

CSDIX vs JIREX

CSDIX vs JIREX Comparison Chart in %
View a ticker or compare two or three
VS
CSDIX vs. JIREX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSDIX is a Hold and JIREX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSDIX has more cash in the bank: 9.36B vs. JIREX (336M). CSDIX pays higher dividends than JIREX: CSDIX (2.80) vs JIREX (1.52). CSDIX was incepted earlier than JIREX: CSDIX (28 years) vs JIREX (21 years). JIREX (0.86) and CSDIX (0.85) have similar cost to investors . JIREX is a more actively managed with annual turnover of: 105.00 vs. CSDIX (27.00). JIREX has a lower initial minimum investment than CSDIX: JIREX (0) vs CSDIX (100000). JIREX annual gain was more profitable for investors over the last year : 14.30 vs. CSDIX (11.77). CSDIX return over 5 years is better than : 13.75 vs. JIREX (-3.03).
CSDIXJIREXCSDIX / JIREX
Total Expense Ratio0.850.85100%
Annual Report Gross Expense Ratio0.850.8699%
Fund Existence28 years21 years-
Gain YTD11.82111.658101%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.36B336M2,785%
Annual Yield % from dividends2.801.52184%
Returns for 1 year11.7714.3082%
Returns for 3 years33.1333.28100%
Returns for 5 years13.75-3.03-454%
Returns for 10 years65.9815.52425%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTH28.170.02
+0.07%
Structured Products CorTS PECO Energy Cap Trust III
DWTX1.49-0.01
-0.67%
Dogwood Therapeutics Inc
NOA13.39-0.11
-0.81%
North American Construction Group Ltd
KT18.26-0.50
-2.67%
KT Corp.
RAPP36.87-1.62
-4.21%
Rapport Therapeutics Inc.